tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Revenue

Compare
282 Followers

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had a revenue of 9.22M in the quarter ending Sep 30, 2024, with 96.29%. This bring the company's revenue in the last twelve months to 23.73M, Decreased 63.51%. In the fiscal year ending Dec 31, 2023, Monte Rosa Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
23.73M
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
134
Market Cap
$279.87M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20230.00
Dec 31, 20220.00
Dec 31, 20210.00
Dec 31, 20200.00
Dec 31, 20190.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis